Our research showed that honeysuckle-derived miR2911 decreased TGF-β1 secretion from colon cancer CT26 cells and increased numbers of T lymphocytes in CT26 tumors, finally resulting in the inhibition of cancer progression. This evidence concerns the gene TGFB1 and malignant colon neoplasm.